Are serious ophthalmic adverse events on dupilumab treatment for atopic dermatitis dose related?

Authors :: Mastorino L
Ortoncelli M
Avallone G
Quaglino P
Ribero S
Source :: International journal of dermatology [Int J Dermatol] 2022 Oct; Vol. 61 (10), pp. e370-e372. Date of Electronic Publication: 2021 Dec 05.
Publication Year :: 2022

Subjects :: Antibodies, Monoclonal, Humanized adverse effects
Eye
Humans
Treatment Outcome
Conjunctivitis chemically induced
Dermatitis, Atopic drug therapy

Full Text Access

Tools